Next generation transposon vectors for genome engineering

用于基因组工程的下一代转座子载体

基本信息

  • 批准号:
    10501335
  • 负责人:
  • 金额:
    $ 52.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Non-viral gene delivery systems are limited by their activity and targeted integration capability. Efficient and targeted integration of DNA into mammalian and human genomes remains a major challenge and its success would have wide impact for biotechnology and therapeutic applications. The piggyBac (PB) transposon system is the most active integrating non-viral gene delivery system and is a cut-and-paste DNA transposon that has been used for genome engineering of mammalian and human cells for more than 15 years. We have re-engineered the PB-transpososome (transposase with transposon DNA) based on the first- ever three-dimensional structure of the PB transpososome that we recently published with our collaborator Dr. Fred Dyda (Chen et al., Nature Communications, 2020). Our next-generation PB transpososome (ngPB) demonstrates greater activity and potential for targeted integration than was previously achievable. In specific aim 1, we will engineer and test ngPB for genome engineering of human cells. We will evaluate the integration site profile and copy number of transposon integrations per human cell. We will modify primary human T cells ex vivio and test their ability for cell therapy, and we will enable transposase protein transfection. In specific aim 2, we will engineer and test ngPB for gene delivery in vivo. We will evaluate gene delivery of reporter and therapeutic transgenes to mouse liver, test for efficiency in development of transgenic mice, and evaluate hybrid adeno-associated viral (AAV)-ngPB mediated gene delivery to difficult to reach organs. In specific aim 3, we will engineer and test ngPB for targeted integration in human cells. We will also map the protein-protein interaction domain of PB known to affect its target site selection in human cells and test PB protein modifications to allow greater flexibility in manipulating PB genomic target site selection. The proposed studies will be transformative for genome engineering and have broad impact for biotechnology and therapeutic applications.
非病毒基因递送系统受到其活性和靶向整合能力的限制。高效和 将DNA靶向整合到哺乳动物和人类基因组中仍然是一个重大挑战, 将对生物技术和治疗应用产生广泛影响。piggyBac(PB)转座子系统 是最活跃的整合非病毒基因递送系统,并且是剪切和粘贴DNA转座子, 已经用于哺乳动物和人类细胞的基因组工程超过15年。我们 基于第一个- 我们最近与合作者发表的PB转座体的三维结构 博士Fred Dyda(Chen等人,Nature Communications,2020)。我们的下一代PB转座体 (ngPB)显示出比以前可实现的更大的活性和有针对性的整合潜力。在 具体目标1,我们将工程化和测试ngPB用于人类细胞的基因组工程。我们将评估 整合位点概况和每个人细胞转座子整合拷贝数。我们将修改主要 体外培养人T细胞并测试其细胞治疗能力,我们将使转座酶蛋白转染成为可能。 在具体目标2中,我们将设计和测试ngPB用于体内基因递送。我们将评估基因传递, 报告基因和治疗性转基因至小鼠肝脏,测试转基因小鼠发育的效率,和 评估杂合腺相关病毒(AAV)-ngPB介导的基因递送至难以到达的器官。在 具体目标3,我们将工程化并测试ngPB在人细胞中的靶向整合。我们还将绘制 已知影响其在人细胞中的靶位点选择的PB的蛋白质-蛋白质相互作用结构域和测试PB 蛋白质修饰以允许在操纵PB基因组靶位点选择中具有更大的灵活性。的 拟议的研究将对基因组工程产生变革性影响,并对生物技术产生广泛影响。 和治疗应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATTHEW H WILSON其他文献

MATTHEW H WILSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATTHEW H WILSON', 18)}}的其他基金

Next generation transposon vectors for genome engineering
用于基因组工程的下一代转座子载体
  • 批准号:
    10688194
  • 财政年份:
    2022
  • 资助金额:
    $ 52.55万
  • 项目类别:
Metabolic consequences of cystinuria and genome engineering therapeutics
胱氨酸尿症和基因组工程疗法的代谢后果
  • 批准号:
    10265368
  • 财政年份:
    2018
  • 资助金额:
    $ 52.55万
  • 项目类别:
Genome engineering therapeutics for cystinuria and its metabolic consequences.
胱氨酸尿症的基因组工程疗法及其代谢后果。
  • 批准号:
    10588590
  • 财政年份:
    2018
  • 资助金额:
    $ 52.55万
  • 项目类别:
Metabolic consequences of cystinuria and genome engineering therapeutics
胱氨酸尿症和基因组工程疗法的代谢后果
  • 批准号:
    9898319
  • 财政年份:
    2018
  • 资助金额:
    $ 52.55万
  • 项目类别:
Pilot and Feasibility Program
试点和可行性计划
  • 批准号:
    10163170
  • 财政年份:
    2017
  • 资助金额:
    $ 52.55万
  • 项目类别:
Kidney specific site-directed integration for cystinuria
肾脏特异性定点整合治疗胱氨酸尿症
  • 批准号:
    8542365
  • 财政年份:
    2013
  • 资助金额:
    $ 52.55万
  • 项目类别:
Novel cell therapy for anemia of CKD
治疗 CKD 贫血的新型细胞疗法
  • 批准号:
    8305209
  • 财政年份:
    2012
  • 资助金额:
    $ 52.55万
  • 项目类别:
Novel cell therapy for anemia of CKD
治疗 CKD 贫血的新型细胞疗法
  • 批准号:
    8708060
  • 财政年份:
    2012
  • 资助金额:
    $ 52.55万
  • 项目类别:
Novel cell therapy for sustained therapeutic protein delivery in vivo
用于体内持续治疗性蛋白质递送的新型细胞疗法
  • 批准号:
    10428544
  • 财政年份:
    2012
  • 资助金额:
    $ 52.55万
  • 项目类别:
Novel cell therapy for sustained therapeutic protein delivery in vivo
用于体内持续治疗性蛋白质递送的新型细胞疗法
  • 批准号:
    10011826
  • 财政年份:
    2012
  • 资助金额:
    $ 52.55万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 52.55万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了